VentiRx Pharmaceuticals

VentiRx Pharmaceuticals

VentiRx Pharmaceuticals

VentiRx Pharmaceuticals develops novel TLR8 therapeutics for the treatment of cancer, allergy, and respiratory and autoimmune diseases.
Founded
2006
Raised
$50.6M
Follow us
Alexa global traffic share
Latest funding
Team Size
10+
Employees
bizjournals , sec

Seattle biopharma startup lands $19.3M in venture funding for cancer research